Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

FMR1NB Inhibitors

Chemical inhibitors of FMR1NB operate by engaging with various cellular signaling pathways that are crucial for the regulation of protein synthesis, a process in which FMR1NB is deeply involved. LY294002 and Wortmannin are potent inhibitors of PI3K, and their action can disrupt the PI3K/AKT/mTOR pathway, a central conduit for signals that promote protein synthesis. By inhibiting this pathway, these chemicals can reduce the general landscape of protein translation within the cell, thereby limiting the regulatory role that FMR1NB plays in the synthesis of specific proteins. Similarly, Rapamycin directly inhibits mTOR, a key downstream effector in the PI3K pathway, and can lead to a reduction in cap-dependent translation, affecting the array of proteins to which FMR1NB is functionally tied. Continuing with this line of targeted intervention, U0126 and PD98059 selectively inhibit MEK1/2 within the ERK/MAPK pathway. This pathway has implications for protein synthesis regulation, which means that inhibiting MEK can have a ripple effect, reaching processes in which FMR1NB is a participant. SB203580 and SP600125, which target p38 MAPK and JNK respectively, can disrupt the stress response and other signaling pathways that indirectly govern the translation of proteins in association with FMR1NB. Moreover, Roscovitine's inhibition of CDKs can affect the cell cycle, which is tied to the broader context of protein synthesis and turnover, influencing FMR1NB's functional sphere. Curcumin, with its broad inhibitory effects on several biochemical pathways, can alter the protein synthesis landscape, leading to a decrease in FMR1NB's associated activities. Cycloheximide, Anisomycin, and Emetine are general protein synthesis inhibitors that block ribosomal function and, although they act broadly, they can impede FMR1NB's role in regulating translation by reducing the overall pool of proteins being synthesized.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a potent inhibitor of PI3K, a kinase involved in signaling pathways linked to protein synthesis regulation. FMR1NB, when functionally active, associates with certain mRNAs and regulates their translation. PI3K inhibition could lead to reduced protein synthesis, indirectly inhibiting FMR1NB-associated translation processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 MAPK. The p38 MAPK signaling pathway is involved in the regulation of protein translation and cellular stress responses. By inhibiting p38 MAPK, SB203580 could reduce the translation of proteins, including those associated with FMR1NB function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor which impacts protein synthesis. Since FMR1NB is known to be involved in the regulation of protein translation, inhibiting mTOR with rapamycin could reduce the protein translation process that FMR1NB regulates.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK, which is part of the ERK/MAPK pathway. This pathway is implicated in the control of protein synthesis and cellular proliferation. Inhibition of MEK could disrupt downstream signaling, potentially inhibiting protein translation processes involving FMR1NB.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent PI3K inhibitor, like LY294002, and would similarly disrupt PI3K-dependent signaling pathways, which could indirectly inhibit the protein synthesis regulatory function of FMR1NB.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 selectively inhibits MEK, which is upstream of ERK in the MAPK pathway. By inhibiting MEK, PD98059 could interfere with protein synthesis regulation, potentially inhibiting processes in which FMR1NB is involved.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, which is involved in stress response signaling pathways. As stress responses can regulate protein synthesis, inhibiting JNK could indirectly affect the function of FMR1NB in this context.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Roscovitine is an inhibitor of cyclin-dependent kinases (CDKs) which are involved in cell cycle regulation. CDK inhibition could indirectly affect cellular processes related to protein synthesis and thus inhibit FMR1NB function.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin has been shown to affect multiple signaling pathways, including those related to the inflammatory response and protein synthesis. Its broad-spectrum activity could potentially inhibit processes in which FMR1NB is functionally involved.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in protein elongation. This inhibition could reduce overall protein synthesis, including that regulated by FMR1NB.